North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.045

-7.9%

Jan 29 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Lee who wrote (210)	1/13/1998 6:15:00 PM
From: Don W Stone	Read Replies (1) of 507

Paul : I suggest that you go and read it. But understand this is not "the street" reporter saying this stuff. This is Sturza who has been recommending short NVX since it was 6 or so. A few quotes are from an Institutional analyst who has a large position in NVX and loves the stock. Note how much space they allocated to her. She represents the bull side. Sturza represents the bear/shorts. Some of what is said in the article is just plain incorrect. The NVX news release did not say that data would be provided to the FDA by the end of the 1qtr or shortly there after. It did say that they expect approval in that time frame . The information ( not data) that was requested will be provided to the FDA over the next 2 weeks is what I understand to be the actual case. The information requested does not involve clinical trials and certainly is not about what Sturza thinks it is. NVX's has show that their efficacy results are better than any of the vaccines presently being marketed in the US. As Andy says: it is laughable. :-}, :-} Be interested in seeing what you think.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next